Skip to main content

Table 1 Patients characteristics

From: Accumulation of blood-circulating PD-L1-expressing M-MDSCs and monocytes/macrophages in pretreatment ovarian cancer patients is associated with soluble PD-L1

Parameters

Ovarian cancer

Control

Material (type)

Blood

Ascites

Tumour tissue

Blood

Subjects, n

43

26

29

15

Age (years), med (min–max)

60 (20–86)

69 (20–86)

52 (20–80)

57 (34–64)

Stage, n (%)

NA

 Early (I/II)

20 (46.5)

6 (23.1)

17 (58.6)

 Advanced (III/IV)

23 (53.5)

20 (76.9)

12 (41.4)

Grade, n (%)

 GII

24 (55.8)

13 (50.0)

11 (37.9)

 GIII

19 (44.20

13 (50.0)

18 (62.1)

Kurman and Shih’s type, n (%)

 I

28 (65.1)

13 (50.0)

21 (72.4)

 II

15 (34.9)

13 (50.0)

8 (27.6)

Histology, n (%)

 Endometrioid

21 (48.8)

7 (26.9)

16 (55.2)

 Serous

18 (41.9)

13 (50.0)

9 (31.0)

 Mucinous

4 (9.3)

6 (23.1)

4 (13.8)

  1. NA not applicable